About Index Trending news
Analyze
Pricing
Aravis Ventures

Aravis Ventures

Aravis Ventures

venture company
I work here Suggest edits
More info

Elsewhere

Also headquartered in Zurich

UBS UBS Ava Ava Ringier AG Ringier AG faceshift faceshift Avaloq Avaloq digitalMedLab GmbH digitalMedLab GmbH Beekeeper Beekeeper STAFF FINDER STAFF FINDER On Running On Running Doodle Doodle

Companies in the same industry

CareCapital CareCapital Pivotal bioVenture Partners Pivotal bioVenture Partners Upstart Digital Ventures Upstart Digital Ventures MassChallenge MassChallenge ENT Biotech Solutions, LLC ENT Biotech Solutions, LLC NCL_Innovation NCL_Innovation European Investment Fund (EIF) European Investment Fund (EIF) hadas hadas ActnerLab ActnerLab The Longevity Fund The Longevity Fund

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 5

Portfolio

Portfolio tracker
Add info

Activity

Past year's investments

Aravis Ventures participated in fewer than 3 rounds over the past year.

Latest rounds

- Synosia Therapeutics: Venture capital (Series C) ($30M)
- NovImmune: Venture capital (Series C) ($54.8M)
- Ambrx: Venture capital (Series D) ($10M)

Main Co-investors

- Versant Ventures
- 5AM Ventures
- Novartis Venture Fund

NovImmune

NovImmune

Biotechnology
Total funding
$137.2M in 4 rounds from 15 investors
By Aravis Ventures
$54.8M Series C in May, 2009
Synosia Therapeutics

Synosia Therapeutics

Biotechnology
Total funding
$91.5M in 3 rounds from 18 investors
By Aravis Ventures
$30M Series C in Oct, 2010
Exit Biotie Therapies, Jan 11, 2011
Ambrx

Ambrx

Biotechnology
Total funding
$55M in 2 rounds from 14 investors
By Aravis Ventures
$10M Series D in Apr, 2009

Want to see the complete list?
Go Pro!